Skip to main content

Alimera Sciences Inc

ALIMDelisted Sep 16, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001267602

Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Alimera Sciences Inc changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of ALIM: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders5210−51
Shares46.4M1.39M0−45.0M (−100.0%)
Value$257.9M$7.70M$0−$250.2M (−100.0%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (0)

Institutions that held Alimera Sciences Inc at the end of Q3 2024 but not at the end of Q2 2024.

None.

Sold out (51)

Institutions that held Alimera Sciences Inc at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of ALIM in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Caligan Partners LP16,835,154$93.6M
Velan Capital Investment Management LP13,608,533$75.7M
Stonepine Capital Management, LLC3,511,816$19.5M
Boothbay Fund Management, LLC3,198,708$17.8M
Altium Capital Management LP2,150,000$12.0M
Vanguard Group Inc1,177,745$6.55M
JPMorgan Chase & Co1,003,617$5.58M
Geode Capital Management, LLC638,396$3.55M
Glazer Capital, LLC551,533$3.07M
Morgan Stanley515,304$2.87M
State Street Corp374,531$2.08M
Renaissance Technologies LLC181,694$1.01M
Bridgeway Capital Management, LLC139,100$773.4K
Deltec Asset Management LLC124,169$690.4K
Gabelli Funds LLC108,000$600.5K
Qube Research & Technologies Ltd97,741$543.4K
Northern Trust Corp86,299$479.8K
Virtu Financial LLC62,284$346.0K
Bank of New York Mellon Corp61,907$344.2K
Gabelli & Co Investment Advisers, Inc.60,650$337.2K
RBF Capital, LLC60,000$333.6K
PenderFund Capital Management Ltd.39,300$298.9K
Charles Schwab Investment Management Inc50,431$280.4K
GTS Securities LLC40,000$222.4K
Cantor Fitzgerald, L. P.37,886$210.6K
Nuveen Asset Management, LLC28,920$160.8K
Gamco Investors, Inc. Et Al25,930$144.2K
Barclays PLC22,791$126.7K
Alliancebernstein L.P.20,850$115.9K
Rhumbline Advisers20,394$113.4K
New York State Common Retirement Fund18,100$100.6K
UBS Group AG17,848$99.2K
Bank of Montreal17,800$99.0K
Jane Street Group, LLC16,895$93.9K
Bank of America Corp14,502$80.6K
Corebridge Financial, Inc.11,526$64.2K
Two Sigma Securities, LLC10,873$60.5K
Invesco Ltd.10,266$57.1K
Millennium Management LLC10,061$55.9K
Wells Fargo & Company7,157$39.8K
Citigroup Inc4,679$26.0K
Legal & General Group Plc2,298$12.8K
Ameritas Investment Partners, Inc.2,099$11.7K
Royal Bank of Canada2,015$11.0K
California State Teachers Retirement System1,552$8.63K
Amalgamated Bank741$4.00K
Tower Research Capital LLC (TRC)694$3.86K
Steward Partners Investment Advisory, LLC666$3.70K
Syntax Research, Inc.80$445
Comerica Bank14$78
GWM Advisors LLC2$12

Not filed for Q3 2024 yet (1)

Institutions that held Alimera Sciences Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ALIM in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.1,385,434$7.70M